Patient Care Alterations After Point-of-Care Laboratory Testing During Critical Care Transport

Patients Air Medical Transport During the COVID-19 Pandemic: A Retrospective Cohort Study

“…Therefore, flight-related conditions, clinical aspects of the underlying disease and the signs and symptoms inherent to SARS-CoV-2 infection compromise the stability of the patient who, depending on their criticality, require mechanical ventilation and vasopressor drugs, 35 especially during air medical transport. Therefore, carrying out laboratory tests at the point of care prior to pre-hospital transport is essential for quick critical decision-making with the aim of promoting assertive and early interventions to mitigate risks to the patient 37 during air transport.…”

Prehospital qSOFA, mSOFA, and NEWS2 performance for sepsis prediction: A prospective, multi-center, cohort study

“…In prehospital care, therefore, in the recent past, initial screening of sepsis required suspicion of infection and application of EWS, but thanks to the incorporation of point-of-care laboratory testing (POCT), basic analytical results are available bedside (11,12). POCT offers an increasing range of biomarkers, reporting results few minutes after the test, and is becoming an increasingly widespread diagnostic resource in Emergency Medical Services (EMS) (13). Based on POCT, new scoring systems have been derived and validated, adding analytical parameters (e.g., lactate, creatinine, urea, ions, venous blood gases) to the classically employed physiological endpoints, improving prediction of clinical outcomes (14)(15)(16).…”